Literature DB >> 17901434

Anthrax vaccine and public health policy.

Martin Meyer Weiss1, Peter D Weiss, Joseph B Weiss.   

Abstract

The Centers for Disease Control and Prevention has classified Bacillus anthracis, the causative organism of anthrax, as a category A potential bioterrorism agent. There are critical shortcomings in the US anthrax vaccine program. Rather than depending on the private sector, the government must assume direct production of anthrax vaccine. The development of a capacity capable of preemptive immunization of the public against anthrax should be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901434      PMCID: PMC2040369          DOI: 10.2105/AJPH.2006.102749

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  32 in total

1.  A no-show vaccine--for a mere $126 million. Deal?

Authors:  E T Pound
Journal:  US News World Rep       Date:  2001-10-29

2.  Bioterrorism. Vaccines for biodefense: a system in distress.

Authors:  J Cohen; E Marshall
Journal:  Science       Date:  2001-10-19       Impact factor: 47.728

3.  Bioterrorism and compulsory vaccination.

Authors:  Tom Jefferson
Journal:  BMJ       Date:  2004-09-04

4.  The fragility of the U.S. vaccine supply.

Authors:  Frank A Sloan; Stephen Berman; Sara Rosenbaum; Rosemary A Chalk; Robert B Giffin
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

5.  The U.S. vaccine supply.

Authors:  Harry K Schwartz
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  Neural tube defect surveillance and folic acid intervention--Texas-Mexico border, 1993-1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-01-14       Impact factor: 17.586

7.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

8.  Forensic application of microbiological culture analysis to identify mail intentionally contaminated with Bacillus anthracis spores.

Authors:  Douglas J Beecher
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

Review 9.  Anthrax vaccines.

Authors:  A M Friedlander; S L Welkos; B E Ivins
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 10.  Information on which to base assessments of risk from environments contaminated with anthrax spores.

Authors:  A Watson; D Keir
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

View more
  6 in total

1.  Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.

Authors:  L K Petersen; Y Phanse; A E Ramer-Tait; M J Wannemuehler; B Narasimhan
Journal:  Mol Pharm       Date:  2012-03-20       Impact factor: 4.939

Review 2.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Glycoconjugates prevent B. anthracis toxin-induced cell death through binding while activating macrophages.

Authors:  Olga Tarasenko; Ashley Scott; Lee Soderberg; Pierre Alusta
Journal:  Glycoconj J       Date:  2011-12-02       Impact factor: 2.916

Review 4.  The social, political, ethical, and economic aspects of biodefense vaccines.

Authors:  Gregory A Poland; Robert M Jacobson; Jon Tilburt; Kristin Nichol
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

5.  Characterization of AmiBA2446, a novel bacteriolytic enzyme active against Bacillus species.

Authors:  Krunal K Mehta; Elena E Paskaleva; Saba Azizi-Ghannad; Daniel J Ley; Martin A Page; Jonathan S Dordick; Ravi S Kane
Journal:  Appl Environ Microbiol       Date:  2013-07-19       Impact factor: 4.792

6.  Investigation of animal anthrax outbreaks in the human-animal interface at risky districts of Bangladesh during 2016-2017.

Authors:  S K Shaheenur Islam; Shovon Chakma; A H M Taslima Akhter; Nelima Ibrahim; Faisol Talukder; Golam Azam Chowdhuary
Journal:  J Adv Vet Anim Res       Date:  2018-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.